Hamlet Protein CEO Erik Visser shared his 2026 market outlook, emphasizing a complex landscape shaped by geopolitical tensions, disease risks and evolving consumer preferences in animal protein production.
Visser noted that while poultry and aquaculture sectors will continue to grow, swine and ruminant production are expected to stabilize or decline slightly. “Growth in animal production will slow to less than half a percent,” he said, highlighting tighter margins driven by disease outbreaks, higher trade costs, and price-sensitive consumers.
Geopolitical risks remain a major concern, especially the U.S.-China trade relationship, which will influence soy and pork exports and global markets. The expiration of the current trade agreement and upcoming U.S. midterm elections add uncertainty. Meanwhile, the European Union’s review of trade ties with China could lead to tariffs or other measures.
Feed costs are forecast to remain stable, allowing producers to invest in specialty ingredients and additives that enhance animal health and performance. Visser stressed the importance of nutritional strategies to help animals reach their genetic potential amid growing regulatory pressures in the U.S. and EU.
Disease outbreaks such as African Swine Fever and Avian Influenza continue to threaten supply chains, prompting increased biosecurity and farm management efforts.
Sustainability is now a strategic imperative, with producers focusing on efficiency, environmental impact reduction, and climate risk management. Hamlet Protein recently completed a Life Cycle Assessment and joined the Science Based Targets Initiative to guide its sustainability roadmap.
Visser also highlighted the role of artificial intelligence in evolving animal nutrition practices, particularly in diet optimization and sustainability initiatives.
Looking ahead, Visser said agility will be key for industry players navigating shifting markets, regulations, and consumer demands. Hamlet Protein aims to grow its specialty soy protein market share by leveraging research on protein kinetics and expanding in ruminant and poultry segments, while maintaining strong ties with the swine industry.
With a global population driving demand for animal protein, Visser remains optimistic about Hamlet Protein’s growth prospects and commitment to innovation in 2026.
